View Older Stories View More Recent Stories

Sep 1, 2020 08:22AM Orexo and Lyfebulb Announce the Finalists and Jury for the 2020 Innovation Challenge in Substance Use Disorders
Aug 10, 2020 02:09AM Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US
Jul 2, 2020 02:34AM Orexo Launches Deprexis® and Vorvida® in the US and Provides Updated Financial Guidance
Jun 30, 2020 02:28AM Positive Results from Human PK Study Assessing Orexo's Intranasal Nalmefene Formulations for Opioid Overdose Reversal
Jun 17, 2020 08:17AM Orexo and Lyfebulb Announce Call for Digital Solutions to Treat Substance Use Disorder
May 29, 2020 11:46AM Number of Shares and Votes in Orexo
May 18, 2020 08:17AM Orexo and Lyfebulb Partner During Unprecedented Times to Help Those Struggling With Alcohol and Opioid Use Disorders
May 11, 2020 02:24AM Orexo Acquires Exclusive US Rights to Commercialize deprexis®, A World-leading Digital Therapy to Help Patients Manage the Symptoms of Depression
Apr 16, 2020 01:56PM James Noble Appointed as Chairman of the Board
Apr 9, 2020 11:39AM The Board of Directors of Orexo Withdraws Proposal on Incentive Program
Apr 6, 2020 02:12AM Orexo Ends Share Buy-back Program
Mar 26, 2020 09:15AM Orexo Publishes the Annual Report for 2019
Mar 25, 2020 04:52PM Orexo Has Repurchased 14 Percent of Own Corporate Bonds
Mar 17, 2020 03:34AM Orexo Presents Sales Potential of the Pharmaceutical Pipeline and Digital Therapies During the Capital Markets Day
Mar 12, 2020 01:08PM Invitation to Attend Orexo's Capital Markets Day via Teleconference
Mar 6, 2020 02:26AM Orexo Submits Application for vorvida® to the FDA to Enable Commercialization in the US
Feb 19, 2020 03:05AM Invitation - Orexo Capital Markets Day, Stockholm, Sweden, March 17
Dec 3, 2019 09:15AM Save the Date: Orexo to Host Capital Markets Day focusing on Digital Health, on March 17, 2020
Dec 2, 2019 02:17AM Orexo Appoints Dennis Urbaniak as Executive Vice President Digital Health
Nov 27, 2019 09:46AM Orexo Acquires Exclusive US Rights to Commercialize Vorvida®, a Digital Therapy for Alcohol Use Disorder with Scientifically Proven Efficacy
Nov 8, 2019 07:14AM Orexo to Present at Jefferies 2019 Healthcare Conference
Oct 14, 2019 12:01PM Orexo´s Nomination Committee for the Annual General Meeting 2020
Aug 20, 2019 02:09AM Orexo Signs Partnership Agreement With GAIA to Develop and Commercialize a new Digital Therapy for the Treatment of Opioid Use Disorder
Jul 10, 2019 02:15AM Orexo Signs License and Supply Agreement With Mundipharma for Zubsolv® in Australia and New Zealand
Jul 9, 2019 11:59AM Orexo Prepays Part of the Corporate Bond Loan
Jun 28, 2019 11:38AM Number of Shares and Votes in Orexo
Jun 12, 2019 11:39AM Issue and Repurchase of Class C Shares
May 31, 2019 11:43AM Number of Shares and Votes in Orexo
May 17, 2019 09:14AM Orexo's Closest Upcoming Presentations at Conferences
Apr 26, 2019 11:42AM Issues of Shares Following the Vesting of 2016/2019 Incentive Plan
Apr 11, 2019 12:54PM Report from Orexo AB's Annual General Meeting
Mar 29, 2019 11:27AM District Court of Delaware Rules that Actavis does not Infringe with their Suboxone® and Subutex® Generics
Mar 21, 2019 05:42AM Orexo Publishes the Annual Report for 2018
Feb 28, 2019 12:11PM Number of Shares and Votes in Orexo
Jan 11, 2019 02:13AM Actavis Infringes Orexo's Long Term Zubsolv® U.S. Patent ´330
Jan 7, 2019 02:15AM Positive Results From Human PK Study Assessing Orexo's New Intranasal Naloxone Formulations for Opioid Overdose Reversal
Dec 13, 2018 01:08AM Orexo Regains Rights to Zubsolv® in all Countries Outside the US
Dec 6, 2018 01:44AM Orexo Hosts Capital Markets Day Today in Stockholm, Sweden
Nov 30, 2018 02:16AM US Court of Appeals Denies Actavis's Petition for Rehearing Regarding Validity of the Zubsolv® Patent
Nov 28, 2018 08:26AM Agenda - Orexo Capital Markets Day, Stockholm, Sweden, Dec. 6
Nov 8, 2018 07:43AM Orexo to Host a Capital Markets Day on Dec. 6 With the US President´s Former Advisor as Keynote Speaker
Oct 24, 2018 07:52AM Save the Date: Orexo to Host Capital Markets Day on Dec. 6 With the US President´s Former Advisor as Key Note Speaker
Oct 24, 2018 02:49AM Orexo Appoints Joseph DeFeo as New CFO
Oct 8, 2018 11:58AM Orexo Appoints Nomination Committee and Publishes Financial Calendar 2018/2019
Oct 1, 2018 02:20AM Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
Jun 29, 2018 12:08PM Number of Shares and Votes in Orexo
Jun 18, 2018 12:38PM Zubsolv® Now Launched in the EU, Which Triggers a EUR 3m Milestone Payment to Orexo
May 31, 2018 02:56AM Orexo´s CFO Resigns and Will Leave the Company in November 2018
Apr 12, 2018 12:24PM Report from Orexo AB's Annual General Meeting
Mar 22, 2018 03:30AM Orexo Publishes the Annual Report for 2017
View More Recent Stories View Older Stories